Annual EBITDA:
$125.50M-$28.70M(-18.61%)Summary
- As of today, EVH annual EBITDA is $125.50 million, with the most recent change of -$28.70 million (-18.61%) on December 31, 2024.
- During the last 3 years, EVH annual EBITDA has risen by +$82.88 million (+194.49%).
- EVH annual EBITDA is now -18.61% below its all-time high of $154.20 million, reached on December 31, 2023.
Performance
EVH EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$24.27M-$2.98M(-10.93%)Summary
- As of today, EVH quarterly EBITDA is $24.27 million, with the most recent change of -$2.98 million (-10.93%) on September 30, 2025.
- Over the past year, EVH quarterly EBITDA has increased by +$6.84 million (+39.24%).
- EVH quarterly EBITDA is now -42.32% below its all-time high of $42.08 million, reached on March 31, 2023.
Performance
EVH Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$108.43M+$6.84M(+6.73%)Summary
- As of today, EVH TTM EBITDA is $108.43 million, with the most recent change of +$6.84 million (+6.73%) on September 30, 2025.
- Over the past year, EVH TTM EBITDA has dropped by -$22.22 million (-17.01%).
- EVH TTM EBITDA is now -33.15% below its all-time high of $162.20 million, reached on December 31, 2023.
Performance
EVH TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
EVH EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -18.6% | +39.2% | -17.0% |
| 3Y3 Years | +194.5% | +7.3% | +43.6% |
| 5Y5 Years | +445.0% | +203.1% | +235.7% |
EVH EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -18.6% | +194.5% | -42.3% | +39.2% | -33.1% | +43.6% |
| 5Y | 5-Year | -18.6% | +445.0% | -42.3% | +203.1% | -33.1% | +235.7% |
| All-Time | All-Time | -18.6% | +314.6% | -42.3% | +182.4% | -33.1% | +284.4% |
EVH EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $24.27M(-10.9%) | $108.43M(+6.7%) |
| Jun 2025 | - | $27.25M(+0.9%) | $101.59M(-11.5%) |
| Mar 2025 | - | $27.00M(-9.7%) | $114.78M(-6.8%) |
| Dec 2024 | $125.50M(-18.6%) | $29.91M(+71.5%) | $123.11M(-5.8%) |
| Sep 2024 | - | $17.43M(-56.9%) | $130.65M(-15.2%) |
| Jun 2024 | - | $40.44M(+14.5%) | $154.04M(-0.9%) |
| Mar 2024 | - | $35.33M(-5.6%) | $155.45M(-4.2%) |
| Dec 2023 | $154.20M(+61.8%) | $37.45M(-8.3%) | $162.20M(+8.5%) |
| Sep 2023 | - | $40.83M(-2.5%) | $149.45M(+13.9%) |
| Jun 2023 | - | $41.85M(-0.5%) | $131.24M(+26.1%) |
| Mar 2023 | - | $42.08M(+70.4%) | $104.09M(+28.7%) |
| Dec 2022 | $95.31M(+123.6%) | $24.69M(+9.2%) | $80.89M(+7.1%) |
| Sep 2022 | - | $22.62M(+53.9%) | $75.50M(+21.5%) |
| Jun 2022 | - | $14.70M(-22.1%) | $62.14M(+2.4%) |
| Mar 2022 | - | $18.88M(-2.2%) | $60.68M(+19.2%) |
| Dec 2021 | $42.62M(+41.9%) | $19.30M(+108.4%) | $50.93M(+6.8%) |
| Sep 2021 | - | $9.26M(-30.1%) | $47.67M(+2.7%) |
| Jun 2021 | - | $13.24M(+45.0%) | $46.41M(+5.8%) |
| Mar 2021 | - | $9.13M(-43.1%) | $43.88M(+8.9%) |
| Dec 2020 | $30.02M(+182.5%) | $16.04M(+100.2%) | $40.30M(+24.7%) |
| Sep 2020 | - | $8.01M(-25.2%) | $32.30M(+49.1%) |
| Jun 2020 | - | $10.71M(+93.2%) | $21.66M(+972.5%) |
| Mar 2020 | - | $5.54M(-31.1%) | -$2.48M(+91.0%) |
| Dec 2019 | -$36.37M | $8.05M(+405.9%) | -$27.50M(-61.7%) |
| Sep 2019 | - | -$2.63M(+80.4%) | -$17.01M(-770.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$13.44M(+31.0%) | $2.54M(-92.9%) |
| Mar 2019 | - | -$19.48M(-205.0%) | $35.87M(-48.9%) |
| Dec 2018 | $68.22M(+383.4%) | $18.55M(+9.6%) | $70.16M(+38.7%) |
| Sep 2018 | - | $16.91M(-15.0%) | $50.60M(+70.5%) |
| Jun 2018 | - | $19.89M(+34.3%) | $29.69M(+3724.7%) |
| Mar 2018 | - | $14.81M(+1558.0%) | -$819.00K(+96.9%) |
| Dec 2017 | -$24.07M(+58.8%) | -$1.02M(+74.6%) | -$26.67M(+51.6%) |
| Sep 2017 | - | -$4.00M(+62.3%) | -$55.12M(+6.3%) |
| Jun 2017 | - | -$10.61M(+3.9%) | -$58.81M(-2.8%) |
| Mar 2017 | - | -$11.04M(+62.5%) | -$57.21M(+0.1%) |
| Dec 2016 | -$58.48M(-63.3%) | -$29.46M(-283.0%) | -$57.28M(-47.3%) |
| Sep 2016 | - | -$7.69M(+14.7%) | -$38.88M(+14.3%) |
| Jun 2016 | - | -$9.02M(+18.8%) | -$45.38M(+3.3%) |
| Mar 2016 | - | -$11.11M(-0.4%) | -$46.91M(-31.0%) |
| Dec 2015 | -$35.81M(>-9900.0%) | -$11.06M(+22.0%) | -$35.81M(-44.7%) |
| Sep 2015 | - | -$14.19M(-34.4%) | -$24.75M(-134.4%) |
| Jun 2015 | - | -$10.55M(>-9900.0%) | -$10.55M(>-9900.0%) |
| Mar 2015 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2014 | $0.00(+100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2014 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2013 | -$19.95M(-5.5%) | - | - |
| Dec 2013 | - | $0.00 | $0.00 |
| Dec 2012 | -$18.91M | - | - |
FAQ
- What is Evolent Health, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. annual EBITDA year-on-year change?
- What is Evolent Health, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. quarterly EBITDA year-on-year change?
- What is Evolent Health, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Evolent Health, Inc.?
- What is Evolent Health, Inc. TTM EBITDA year-on-year change?
What is Evolent Health, Inc. annual EBITDA?
The current annual EBITDA of EVH is $125.50M
What is the all-time high annual EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high annual EBITDA is $154.20M
What is Evolent Health, Inc. annual EBITDA year-on-year change?
Over the past year, EVH annual EBITDA has changed by -$28.70M (-18.61%)
What is Evolent Health, Inc. quarterly EBITDA?
The current quarterly EBITDA of EVH is $24.27M
What is the all-time high quarterly EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high quarterly EBITDA is $42.08M
What is Evolent Health, Inc. quarterly EBITDA year-on-year change?
Over the past year, EVH quarterly EBITDA has changed by +$6.84M (+39.24%)
What is Evolent Health, Inc. TTM EBITDA?
The current TTM EBITDA of EVH is $108.43M
What is the all-time high TTM EBITDA for Evolent Health, Inc.?
Evolent Health, Inc. all-time high TTM EBITDA is $162.20M
What is Evolent Health, Inc. TTM EBITDA year-on-year change?
Over the past year, EVH TTM EBITDA has changed by -$22.22M (-17.01%)